Assignee
REATA PHARMACEUTICALS HOLDINGS LLC
US·6 granted patents·6 pending applications·5 citations·filing 2021–2025
Top patents by PatentIndex Score
12 records- 0195US12065464B22,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereofREATA PHARMACEUTICALS HOLDINGS LLC·Filed 2021·Granted Aug 20, 2024·2 cites·18 claims
- 0292US11919838B2Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17REATA PHARMACEUTICALS HOLDINGS LLC·Filed 2021·Granted Mar 5, 2024·1 cites·16 claims
- 0391US11873320B22,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereofREATA PHARMACEUTICALS HOLDINGS LLC·Filed 2021·Granted Jan 16, 2024·2 cites·10 claims
- 0489US12358866B2Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17REATA PHARMACEUTICALS HOLDINGS LLC·Filed 2024·Granted Jul 15, 2025·0 cites·30 claims
- 0589US2025051388A12,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereofREATA PHARMACEUTICALS HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 0687US2025353813A1Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17REATA PHARMACEUTICALS HOLDINGS LLC·Filed 2025·Application pending·0 cites
- 0783US12384815B22,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereofREATA PHARMACEUTICALS HOLDINGS LLC·Filed 2024·Granted Aug 12, 2025·0 cites·19 claims
- 0876US2024115542A1Methods of treating and preventing endothelial dysfunction using bardoxolone methyl or analogs thereofREATA PHARMACEUTICALS HOLDINGS LLC·Filed 2023·Application pending·0 cites
- 0976US2024335457A1Methods of treating obesity using antioxidant inflammation modulatorsREATA PHARMACEUTICALS HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 1067US11446313B2Methods of treating Alport syndrome using bardoxolone methyl or analogs thereofREATA PHARMACEUTICALS HOLDINGS LLC·Filed 2021·Granted Sep 20, 2022·0 cites·30 claims
- 1156US2024293351A1Methods of administering synthetic triterpenoidsREATA PHARMACEUTICALS HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 1253US2023255982A1Methods of treating covid-19 using bardoxolone methyl or analogs thereofREATA PHARMACEUTICALS HOLDINGS LLC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when REATA PHARMACEUTICALS HOLDINGS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →